Cargando…
Intraovarian insertion of autologous platelet growth factors as cell-free concentrate: Fertility recovery and first unassisted conception with term delivery at age over 40
BACKGROUND: The use of autologous platelet-rich plasma as an ovarian treatment has not been standardized and remains controversial. CASE PRESENTATION: A 41½-year old woman with diminished ovarian reserve (serum anti- Müllerian hormone = 0.163 mg/mL) and a history of 10 unsuccessful in vitro fertiliz...
Autores principales: | Sills, E. Scott, Rickers, Natalie S., Wood, Samuel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Knowledge E
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778756/ https://www.ncbi.nlm.nih.gov/pubmed/33426419 http://dx.doi.org/10.18502/ijrm.v18i12.8030 |
Ejemplares similares
-
Multichannel Recovery Potential with Activated Autologous Intraovarian Platelet-Rich Plasma and Its Derivatives
por: Sills, E. Scott, et al.
Publicado: (2023) -
Is autologous platelet activation the key step in ovarian therapy for fertility recovery and menopause reversal?
por: Rickers, Natalie S., et al.
Publicado: (2022) -
Normalized Ploidy Following 20 Consecutive Blastocysts with Chromosomal Error: Healthy 46, XY Pregnancy with IVF after Intraovarian Injection of Autologous Enriched Platelet-derived Growth Factors
por: Sills, E. Scott, et al.
Publicado: (2019) -
Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes
por: Wood, Samuel H., et al.
Publicado: (2020) -
Appraisal of Experimental Methods to Manage Menopause and Infertility: Intraovarian Platelet-Rich Plasma vs. Condensed Platelet-Derived Cytokines
por: Sills, E. Scott, et al.
Publicado: (2021)